<ѻý>No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsyѻý> No effect on anxiety but significantly less patient-rated pain Jan 12, 2024
<ѻý>Trump-Era Conscience Rule Rescinded; Lloyd Austin's Cancer; Sinead O'Connor's Deathѻý> Health news and commentary from around the Web gathered by ѻý staff Jan 10, 2024
<ѻý>More Evidence Linking ADT for Prostate Cancer to Adverse Neurocognitive Effectsѻý> Meta-analysis shows increased risk of dementia, Parkinson's, depression Jan 09, 2024
<ѻý>Cancer Patients Face Frightening Delays in Treatment Approvalsѻý> "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
<ѻý>FDA Warns Amazon Over Supplements Containing Erectile Dysfunction Drugsѻý> Agency bought and tested products that were found to contain tadalafil and sildenafil Dec 29, 2023
<ѻý>Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Riskѻý> No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
<ѻý>Shorter Antibiotic Course Noninferior for UTI Recurrence in Kidsѻý> 5-day course should minimize adverse effects, reduce healthcare costs, and improve adherence Dec 26, 2023
<ѻý>You Think the TREE Is Crooked: Penile Fractures Up at Christmasѻý> Painful sex-related injuries jump as stockings are stuffed, German study finds Dec 22, 2023
<ѻý>Iodine Linked With Men's Testosterone Levelsѻý> Results suggest "excess iodine is not harmless," said researcher Dec 21, 2023
<ѻý>Sharp Uptick in Gender-Affirming Hormone Therapy Visits After ACA's Passageѻý> Large database analysis shows room for more HIV testing, prevention Dec 18, 2023
<ѻý>FDA Approves New First-Line Standard of Care in Bladder Cancerѻý> Enfortumab vedotin plus pembrolizumab doubled survival as compared with chemotherapy Dec 15, 2023
<ѻý>FDA Approves Belzutifan for Advanced Renal Cell Carcinomaѻý> HIF-2 inhibitor indicated for patients who progress after immunotherapy and anti-VEGF Dec 15, 2023
<ѻý>TULSA Effective in Controlling Prostate Cancer Long-Termѻý> At 5 years, median PSA was reduced by 90% Dec 05, 2023
<ѻý>'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene?ѻý> Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance Dec 04, 2023
<ѻý>Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancerѻý> Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
<ѻý>Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancerѻý> Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
<ѻý>Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomyѻý> Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
<ѻý>'We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinomaѻý> Potential standard of care after current therapies, but key obstacles remain in the way Nov 15, 2023
<ѻý>Targeting New Pathways to Improve Outcomes in Renal Cell Carcinomaѻý> Building on recent success requires intervention at multiple steps in the cancer immunity cycle Nov 14, 2023
<ѻý>Tyrosine Kinase Inhibitor Active in Heavily Treated Renal Cell Carcinomaѻý> Responses to "special drug" zanzalintinib in cabozantinib-exposed and unexposed patients Nov 11, 2023
<ѻý>Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparitiesѻý> A "local heroes effect" can better reach communities of color Nov 09, 2023
<ѻý>Transitioning Cancer Survivors Away From Oncologic Careѻý> It's time for a new model of care Nov 03, 2023
<ѻý>Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPCѻý> Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
<ѻý>Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPCѻý> Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
<ѻý>Randomized Trial Backs HIF-2a Inhibition in Advanced RCCѻý> After immunotherapy-TKI failure, belzutifan produces better outcomes versus everolimus Oct 24, 2023
<ѻý>Landmark Trial Produces New First-Line Standard for Advanced Bladder Cancerѻý> Enfortumab vedotin-pembrolizumab doubles OS, PFS versus chemotherapy Oct 22, 2023
<ѻý>Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfersѻý> Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
<ѻý>Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train?ѻý> It's time for clear guidelines Oct 18, 2023
<ѻý>Single Dose of Antibiotic Cured Early Syphilis, Even in Those With HIVѻý> One dose proved noninferior to triple-dose regimen in randomized trial Oct 16, 2023
<ѻý>Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBCѻý> Complete clinical response predicted favorable outcomes for up to 2 years Oct 06, 2023
<ѻý>SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancerѻý> Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
<ѻý>FDA OKs Another Injectable for Rare Kidney Disorderѻý> Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
<ѻý>SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancerѻý> Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
<ѻý>Global Incidence of Early-Onset Cancer Has Surged Since 1990ѻý> Early-onset breast cancer has highest incidence and mortality rates Sep 06, 2023
<ѻý>Prostate Cancer Is Not Just an 'Old Man's Disease'ѻý> Spreading this message can save lives Sep 02, 2023
<ѻý>Testosterone Loss in Older Men: Factors Beyond Age in the Mixѻý> Several lifestyle, health factors associated with declining levels Aug 28, 2023
<ѻý>Does Cancer Screening Actually Extend Lives?ѻý> A series of articles look at whether the benefits for the few warrant the harms for the many Aug 28, 2023
<ѻý>Gender Affirming Surgeries Nearly Tripled in the U.S. From 2016 to 2019ѻý> Breast and chest procedures most common, followed by genital reconstruction Aug 25, 2023
<ѻý>FDA Grants De Novo Request for Neuromodulatory System for Urge Incontinenceѻý> Three-fourths of patients had 50% reduction in incontinence at 6 months, 82% at 12 months Aug 18, 2023
<ѻý>Older Surgical Procedure for Pelvic Prolapse Repair Prevails in Randomized Trialѻý> Another study showed vaginal estrogen during prolapse repair did not affect surgical outcomes Aug 17, 2023